Impaired leptin action, referred to as leptin resistance, is an important risk for obesity, and leptin resistance impedes leptin therapy to combat obesity and related metabolic disease (2, 4). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.